Publications

Cost-Effectiveness of Stroke Prophylaxis for Nonvalular Atrial Fibrillation

Letter

Authors
BF Gage
AB Cardinalli
GW Albers
Douglas K. Owens - Stanford University

Published by
Journal of the American Medical Association, Vol. 275, page(s) 909-910
1996

Topics: Comparative effectiveness research | United States

Publications of interest

Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Non-Valvular Atrial Fibrillation
BF Gage, AB Cardinalli, GW Albers, Douglas K. Owens
Journal of the American Medical Association vol. 274 (1995)
Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients Who Have Nonvalvular Atrial Fibrillation
B.F. Gage, A.B. Cardinalli, Douglas K. Owens
Stroke vol. 29 (1998)
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
James Freeman, Ruo Zhu, Douglas K. Owens, Alan M. Garber, David Hutton, Alan Go, Paul Wang, Mintu Turakhia
Annals of Internal Medicine (2010)
Effect of Stroke and Stroke Prophylaxis with Aspirin or Warfarin Therapy on Quality of Life, The
B.F. Gage, A.B. Cardinalli, Douglas K. Owens
Archives of Internal Medicine vol. 156 (1996)